Nautilus Biotechnology, Inc.
NAUT
$2.35
$0.020.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.86% | 16.64% | 10.53% | 5.68% | -1.81% |
| Total Depreciation and Amortization | -2.40% | 0.43% | 1.94% | 3.93% | 5.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -48.68% | -49.10% | -25.49% | -12.74% | 2.81% |
| Change in Net Operating Assets | 8.01% | 34.35% | 23.01% | -7.58% | -19.98% |
| Cash from Operations | 12.24% | 14.29% | 10.40% | 4.62% | -2.46% |
| Capital Expenditure | 36.10% | 55.69% | 10.26% | 4.42% | -2.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.15% | -47.20% | 863.78% | 493.50% | 1,299.67% |
| Cash from Investing | -52.77% | -46.83% | 700.39% | 634.10% | 903.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 41.88% | -81.29% | -42.22% | -16.81% | 49.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 41.88% | -81.29% | -42.22% | -16.81% | 49.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -347.86% | -284.97% | 127.93% | 120.00% | 111.97% |